| Ident. | Authors (with country if any) | Title |
|---|
| 000064 |
Ana Budimir [Croatie] | Metal ions, Alzheimer's disease and chelation therapy |
| 000132 |
M. Andersson [Suède] ; H. Zetterberg [Suède] ; L. Minthon [Suède] ; K. Blennow [Suède] ; E. Londos [Suède] | The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia |
| 000133 |
Brian Jeynes [Canada] ; John Provias [Canada] | The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease |
| 000261 |
Alisha E. King [États-Unis] ; Jim Mintz [États-Unis] ; Donald R. Royall [États-Unis] | Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders |
| 000341 |
E. Mulin [France] ; E. Leone [France] ; K. Dujardin [France] ; M. Delliaux [France] ; A. Leentjens [Pays-Bas] ; F. Nobili [Italie] ; B. Dessi [Italie] ; O. Tible [France] ; L. Agüera-Ortiz [Espagne] ; R. S. Osorio [Espagne] ; J. Yessavage [États-Unis] ; D. Dachevsky [Argentine] ; F. Rj. Verhey [Pays-Bas] ; Alfonso J. Cruz Jentoft [Espagne] ; O. Blanc [France] ; P. M Llorca [France] ; P. H. Robert [France] | Diagnostic criteria for apathy in clinical practice |
| 000343 |
Friederike Fritze [Norvège] ; Uwe Ehrt [Norvège] ; Hogne S Nnesyn [Norvège] ; Martin Kurz [Norvège] ; Tibor Hortobágyi [Royaume-Uni] ; Sabine Piepenstock Nore [Norvège] ; Clive Ballard [Royaume-Uni] ; Dag Aarsland [Norvège] | Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features |
| 000373 |
Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis] | Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias |
| 000522 |
Dylan G. Harwood [États-Unis] ; Ari Kalechstein [États-Unis] ; Warren W. Barker [États-Unis] ; Silvia Strauman [États-Unis] ; Peter St. George-Hyslop [Canada] ; Casandra Iglesias [États-Unis] ; David Loewenstein [États-Unis] ; Ranjan Duara [États-Unis] | The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease |
| 000533 |
J. S. K. Kauwe [États-Unis] ; S. Bertelsen [États-Unis] ; K. Mayo [États-Unis] ; C. Cruchaga [États-Unis] ; R. Abraham [Royaume-Uni] ; P. Hollingworth [Royaume-Uni] ; D. Harold [Royaume-Uni] ; M. J. Owen [Royaume-Uni] ; J. Williams [Royaume-Uni] ; S. Lovestone [Royaume-Uni] ; J. C. Morris [États-Unis] ; A. M. Goate [États-Unis] | Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease |
| 000644 |
Elan D. Louis [États-Unis] ; Ming X. Tang [États-Unis] ; Nicole Schupf [États-Unis] | Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population‐based study of elders |
| 000709 |
Elan D. Louis [États-Unis] | Functional correlates of lower cognitive test scores in essential tremor |
| 000806 |
Debby Tsuang ; Eric B. Larson ; Ge Li ; Jane B. Shofer ; Kathleen S. Montine ; Mary Lou Thompson ; Joshua A. Sonnen ; Paul K. Crane ; James B. Leverenz ; Thomas J. Montine | Association Between Lifetime Cigarette Smoking and Lewy Body Accumulation |
| 000909 |
Berend Arnold Ploeger [Pays-Bas] ; Nicholas H. G. Holford [Nouvelle-Zélande] | Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis |
| 000A65 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
| 000A83 |
Osamu Yokota [Japon] | Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis |
| 000B39 |
Takashi Haraguchi ; Seishi Terada ; Hideki Ishizu ; Kenichi Sakai ; Yasuyuki Tanabe ; Taiji Nagai ; Hiroshi Takata ; Keigo Nobukuni ; Yuetsu Ihara ; Tetsuyuki Kitamoto [Japon] ; Shigetoshi Kuroda | Coexistence of Creutzfeldt‐Jakob disease, Lewy body disease, and Alzheimer's disease pathology: An autopsy case showing typical clinical features of Creutzfeldt‐Jakob disease |
| 000C74 |
James Scott Miners [Royaume-Uni] ; Shabnam Baig [Royaume-Uni] ; Jennifer Palmer [Royaume-Uni] ; Laura E. Palmer [Royaume-Uni] ; Patrick G. Kehoe [Royaume-Uni] ; Seth Love [Royaume-Uni] | SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease |
| 000D47 |
Rajnish K. Chaturvedi [États-Unis] ; M. Flint Beal [États-Unis] | Mitochondrial Approaches for Neuroprotection |
| 000E21 |
Li [République populaire de Chine] ; Clifford R. Jack [États-Unis] ; Xi-Fei Yang [République populaire de Chine] ; Edward S. Yang [République populaire de Chine] | Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: An in vivo volume MRI study |
| 000F57 |
Margaret A. Piggott [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; Elise Rowan [Royaume-Uni] ; Clive Holmes [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; Evelyn Jaros [Royaume-Uni] ; Robert H. Perry [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline |
| 000F68 |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| 001036 |
Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël] | Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil |
| 001097 |
M. Kitayama [Japon] ; K. Wada-Isoe [Japon] ; K. Nakaso [Japon] ; Y. Irizawa [Japon] ; K. Nakashima [Japon] | Clinical evaluation of Parkinson’s disease dementia: association with aging and visual hallucination |
| 001133 |
Leung Wing Chu [Hong Kong] ; Yan Li [Hong Kong] ; Zhong Li [Hong Kong, République populaire de Chine] ; Alan Yb Tang [Hong Kong] ; Bernard My Cheung [Hong Kong] ; Raymond Yh Leung [Hong Kong] ; Ping-Yiu Yik [Hong Kong] ; Dong-Yan Jin [Hong Kong] ; You-Qiang Song [Hong Kong] | A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese |
| 001162 |
Pietro Tiraboschi ; David P. Salmon ; Lawrence A. Hansen ; Richard C. Hofstetter ; Leon J. Thal ; Jody Corey-Bloom | What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? |
| 001281 |
A. Cagnin [Italie] ; M. Kassiou [Australie] ; S. R. Meikle [Australie] ; R. B. Banati [Australie] | In vivo evidence for microglial activation in neurodegenerative dementia |
| 001334 |
Lawrence S. Mayer [États-Unis] ; R. Curt Bay [États-Unis] ; Antonios Politis [États-Unis] ; Martin Steinberg [États-Unis] ; Cynthia Steele [États-Unis] ; Alva S. Baker [États-Unis] ; Peter V. Rabins [États-Unis] ; Constantine G. Lyketsos [États-Unis] | Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS |
| 001363 |
Giuseppina Candore [Italie] ; Carmela R. Balistreri [Italie] ; Maria P. Grimaldi [Italie] ; Sonya Vasto [Italie] ; Florinda Listì [Italie] ; Martina Chiappelli [Italie] ; Federico Licastro [Italie] ; Domenico Lio [Italie] ; Calogero Caruso [Italie] | Age‐Related Inflammatory Diseases |
| 001426 |
Urs P. Mosimann ; Rene M. Mu Ri ; David J. Burn ; Jacques Felblinger [France] ; John T. O'Brien ; Ian G. Mckeith | Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies |
| 001441 |
Louise M. Allan [Royaume-Uni] ; Clive G. Ballard [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] | Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias |
| 001528 |
S. Papapetropoulos [États-Unis] ; A. Lieberman [États-Unis] ; J. Gonzalez [États-Unis] ; D. C. Mash [États-Unis] | Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease? |
| 001586 |
E. I. Agorogiannis [Grèce] ; G. I. Agorogiannis [Grèce] ; A. Papadimitriou [Grèce] ; G. M. Hadjigeorgiou [Grèce] | Protein misfolding in neurodegenerative diseases |
| 001589 |
Francesca Cormack [Royaume-Uni] ; Dag Aarsland [Norvège] ; Clive Ballard [Royaume-Uni] ; Martin J. Tovée [Royaume-Uni] | Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia |
| 001619 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Inflammation and the Degenerative Diseases of Aging |
| 001662 |
Enrique Noe [États-Unis, Espagne] ; Karen Marder [États-Unis] ; Karen L. Bell [États-Unis] ; Diane M. Jacobs [États-Unis] ; Jennifer J. Manly [États-Unis] ; Yaakov Stern [États-Unis] | Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia |
| 001698 |
Sudeep S. Gill [Canada] ; Paula A. Rochon [Canada] ; Mark Guttman [Canada] ; Andreas Laupacis | The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia |
| 001728 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 001734 |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 001828 |
P. H. Robert [France] ; S. Clairet [France] ; M. Benoit [France] ; J. Koutaich [France] ; C. Bertogliati [France] ; O. Tible [France] ; H. Caci [France] ; M. Borg [France] ; P. Brocker [France] ; P. Bedoucha [France] | The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment |
| 001849 |
Eliezer Masliah [États-Unis] ; Lawrence A. Hansen [États-Unis] ; Edward Rockenstein [États-Unis] ; Makoto Hashimoto [États-Unis] | Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases |
| 001868 |
Jaeseung Jeong [Corée du Sud] | Nonlinear dynamics of EEG in Alzheimer's disease |
| 001925 |
Lorna Schumann ; Jennifer Hagerty Lingler ; Daniel I. Kaufer | Cognitive and Motor Symptoms in Dementia: Focus on Dementia with Lewy Bodies |
| 001A40 |
Elaine K. Perry [Royaume-Uni] ; Carmen M. Martin-Ruiz [Royaume-Uni] ; Jennifer A. Court [Royaume-Uni] | Nicotinic receptor subtypes in human brain related to aging and dementia |
| 001A45 |
Luc P. De Vreese [Italie] ; Mirco Neri [Italie] ; Mario Fioravanti [Italie] ; Luciano Belloi [Italie] ; Orazio Zanetti [Italie] | Memory rehabilitation in Alzheimer's disease: a review of progress |
| 001B50 |
K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Uéda [Japon] ; F. Checler [France] | α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells |
| 001B77 |
Rodger J. Elble [États-Unis] ; Keith Leffler [États-Unis] | Pushing and pulling with the upper extremities while standing: The effects of mild Alzheimer dementia and Parkinson's disease |
| 001B98 |
John E. Duda [États-Unis] ; Virginia M. Lee [États-Unis] ; John Q. Trojanowski [États-Unis] | Neuropathology of synuclein aggregates |
| 001D30 |
David F. Clayton ; Julia M. George | Synucleins in synaptic plasticity and neurodegenerative disorders |
| 001D34 |
M. A. Piggott ; E. F. Marshall ; N. Thomas ; S. Lloyd ; J. A. Court ; E. Jaros ; D. Burn ; M. Johnson ; R. H. Perry ; I. G. Mckeith ; C. Ballard ; E. K. Perry | Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution |
| 001E70 |
J. William Langston ; Savitha Sastry ; Piu Chan ; Lysia S. Forno ; Laurel M. Bolin ; Donato A. Di Monte | Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease |
| 001E72 |
Manuel B. Graeber [Allemagne] ; Eva Grasbon-Frodl [Allemagne] ; Ulrich V. Eitzen [Allemagne] ; Siegfried Kösel [Allemagne] | Neurodegeneration and aging: Role of the second genome |
| 002055 |
Rafael Rodríguez-Puertas [Espagne] ; Julio Pascual [Espagne] ; Teresa Vilar [Espagne] ; Ángel Pazos [Espagne] | Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease |
| 002056 |
R. Egensperger [Allemagne] ; S. Kösel [Allemagne] ; N. M. Schnopp [Allemagne] ; P. Mehraein [Allemagne] ; M. B. Graeber [Allemagne] | Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases |
| 002161 |
Michael D. Brown [Géorgie (pays)] ; John M. Shoffner [Géorgie (pays)] ; Yoon L. Kim [Géorgie (pays)] ; Albert S. Jun [Géorgie (pays)] ; Brett H. Graham [Géorgie (pays)] ; Margaret F. Cabell [Géorgie (pays)] ; Daniel S. Gurley [Géorgie (pays)] ; Douglas C. Wallace [Géorgie (pays)] | Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients |
| 002207 |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
| 002303 |
Ahlskog [États-Unis] ; Ryan J. Uitti [États-Unis] ; Phillip A. Low [États-Unis] ; Gertrude M. Tyce [États-Unis] ; Kim K. Nickander [États-Unis] ; Ronald C. Petersen [États-Unis] ; Emre Kokmen [États-Unis] | No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease |
| 002344 |
Campion [France] ; M. Martinez [France] ; D. Hannequin ; A. Brice [France] ; C. Thomas-Anterion [France] ; A. Michon [France] ; M. C. Babron [France] ; B. Dubois [France] ; Y. Goas [France] ; A. Jaillard-Serradt [France] ; F. Ledoze [France] ; F. Pasquier [France] ; M. Puel [France] ; M. A. Zimmerman [France] ; M. Bellis [France] ; J. Mallet [France] ; Yves Agid [France] ; F. Clerget-Darpoux [France] | Characteristics of familial aggregation in early‐onset Alzheimer's disease: Evidence of subgroups |
| 002345 |
I. P. Chessell [Royaume-Uni] ; P. T. Francis [Royaume-Uni] ; D. M. Bowen [Royaume-Uni] | Changes in Cortical Nicotinic Acetylcholine Receptor Numbers Following Unilateral Destruction of Pyramidal Neurones by Intrastriatal Volkensin Injection |
| 002352 |
G. Mathé [France] | Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects |
| 002358 |
John Hardy [États-Unis] | Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease |
| 002367 |
Glosser [États-Unis] ; Christopher Clark [États-Unis] ; Bruce Freundlich [États-Unis] ; Lori Kliner-Krenzel [États-Unis] ; Phyllis Flaherty [États-Unis] ; Matthew Stern [États-Unis] | A controlled investigation of current and premorbid personality: Characteristics of Parkinson's disease patients |
| 002464 |
P. D. Griffiths [Royaume-Uni] ; R. H. Perry [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] | A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease |
| 002603 |
J. C. Pin [France] ; J. P. Neau [France] ; J. Paquereau [France] ; C. Rostykus [France] ; D. Guehl [France] ; I. Aubert [France] ; A. Marillaud [France] ; R. Gil [France] | Étude comparative de la démence de type Alzheimer et de celle de la maladie de Parkinson en EEG quantifiée |
| 002604 |
P. Dustin [Belgique] ; J.-P. Brion [Belgique] ; J. Flament-Durand [Belgique] | What's new in the pathology of neuronal cytoskeleton: The significance of neurofibrillary tangles |
| 002605 |
L. Lorigados [Suède, Cuba] ; S. Söderström [Suède] ; T. Ebendal [Suède] | Two‐site enzyme immunoassay for βNGF applied to human patient sera |
| 002642 |
Larry Baum [États-Unis] ; Eliezer Masliah [États-Unis] ; Devin S. Iimoto [États-Unis] ; Lawrence A. Hansen [États-Unis] ; William C. Halliday ; Tsunao Saitoh [États-Unis] | Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments |
| 002676 |
R. N. Kalaria [États-Unis] ; P. G. Galloway [États-Unis] ; G. Perry [États-Unis] | Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders |
| 002779 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
| 002838 |
Lars G. Forssell [Suède] ; Roland Eklöf [Suède] ; Bengt Winblad [Suède] ; Lars Forssell [Suède] | Early Stages of Late Onset Alzheimer's Disease |
| 002872 |
J. P. Kesslak [États-Unis] ; C. W. Cotman [États-Unis] ; H. C. Chui [États-Unis] ; S. Van Den Noort [États-Unis] ; H. Fang [États-Unis] ; R. Pfeffer [États-Unis] ; G. Lynch [États-Unis] | Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease |
| 002A10 |
John P. Blass [États-Unis] ; Laurie L. Barclay [États-Unis] | New developments in the diagnosis of the dementias |
| 002B26 |
Raimo Sulkava [Finlande] | Alzheimer's disease and senile dementia of Alzheimer type |
